CN Patent
CN105481843A — 一种恩格列净无定型物及其制备方法
Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2016-04-13 · 10y expired
What this patent protects
本发明涉及一种恩格列净无定型物及其制备方法,该无定型物稳定,适合制剂生产。还包括含有恩格列净无定型物的药物组合物以及治疗糖尿病的用途。
USPTO Abstract
本发明涉及一种恩格列净无定型物及其制备方法,该无定型物稳定,适合制剂生产。还包括含有恩格列净无定型物的药物组合物以及治疗糖尿病的用途。
Drugs covered by this patent
- Jardiance (empagliflozin) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.